Status:

UNKNOWN

Cognitive Rehabilitation of Glioma Patients

Lead Sponsor:

UMC Utrecht

Collaborating Sponsors:

Dutch Cancer Society

Conditions:

Glioma

Cognition Disorders

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine whether cognitive rehabilitation is effective in patients with gliomas (brain tumour), by comparing direct and follow-up neuropsychological functioning and qu...

Detailed Description

The majority of patients with (low-grade) glioma exhibit cognitive symptoms and objective deficits, which have a sustained, negative impact on daily functioning and quality of life. Adult patients wi...

Eligibility Criteria

Inclusion

  • adult patients with a histologically proven low-grade glioma or presumed (i.e., suspected) low-grade glioma based on both clinical and MR imaging feature, and
  • adult patients with an anaplastic glioma (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligo-astrocytoma) under age 50 and with good performance status (KPS \> 70);
  • who are clinically stable for a minimum of 6 months prior to study entry (as determined by recent CT or MRI imaging) and no anti-tumor treatment during that period of time (i.e., surgery, radiotherapy, chemotherapy, corticosteroids);
  • who report at least one symptom of impaired cognitive functioning based on a standardized self-report questionnaire, administered by researcher;
  • and who meet criteria for neuropsychological impairment based on objective test results (assessed by researcher).

Exclusion

  • lack of basic proficiency in Dutch;
  • IQ below 85;
  • severe reading problems;
  • an additional (history of) neurological or psychiatric disorder;
  • participating in a concurrent study in which neuropsychological testing and/or health-related quality of life assessments are involved

Key Trial Info

Start Date :

October 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT00256425

Start Date

October 1 2003

End Date

September 1 2007

Last Update

March 21 2008

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

VU Medical Center

Amsterdam, Netherlands, 1007 MB

2

Netherlands Cancer Institute

Amsterdam, Netherlands, 1066 CX

3

UMC Groningen

Groningen, Netherlands, 9700 RB

4

AZ Maastricht

Maastricht, Netherlands, 6202 AZ